Apr 16, 2021
Global Autoimmune Disease Therapeutics Market report helps to make critical decision by providing industry statistics such as size, share, supply chain analysis and regional segments.

Dallas, United States - April 15, 2021 /MarketersMedia/ —
Global Autoimmune Disease Therapeutics Market 2021-2025:
Country Coverage: North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Company Coverage: Roche Holding AG, Pfizer Inc., Johnson & Johnson, Abbott Laboratories
Scope of the Report:
The report titled “Global Autoimmune Disease Therapeutics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the global autoimmune disease therapeutics market by value, by drug class, by indication, by region, etc. The report provides a regional analysis of the autoimmune disease therapeutics market, including the following regions: North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The report also provides a detailed analysis of the COVID-19 impact on the autoimmune disease therapeutics market.
Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/5639637
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global autoimmune disease therapeutics market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global autoimmune disease therapeutics market is fragmented with many major market players operating worldwide. The key players of the autoimmune disease therapeutics market are Roche Holding AG, Pfizer Inc., Johnson & Johnson, and Abbott Laboratories are also profiled with their financial information and respective business strategies.
Executive Summary:
An autoimmune disease is a condition in which the body’s immune system attacks and destroys healthy cells and tissues in the body by mistake. In other words, autoimmune disease arises when the immune system fails to distinguish between the body’s own cells and foreign cells. These diseases can affect any part of the body. Autoimmune disease therapeutics is a form of treatment to calm the overactive immune response, to limit tissue damage, and to reduce pain and inflammation. Treatment can also help in relieving symptoms like pain, swelling, and skin rashes.
There are a lot of therapeutic alternatives available, but no option has a perfect safety profile. Infact, while some treatments have been effective in treating certain autoimmune disorders, no treatment is effective for all autoimmune diseases.
The autoimmune disease therapeutics market can be segmented on the basis of drug class (Immunosuppressant’s, Anti-inflammatory Drug, Interferons, NSAIDs, Antihyperglycemics, and Others); indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes, Psoriasis, and Others); and distribution channel (Hospital & Clinics, Pharmacies, Drug Stores, Online Stores, and Others).
The global autoimmune disease therapeutics market has increased significantly during the years 2018-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The autoimmune disease therapeutics market is expected to increase due to rapid urbanization, escalating healthcare spending, rising prevalence of autoimmune diseases, favorable government initiatives, etc. Yet the market faces some challenges such as high cost involved, lack of approved treatment for IPF (Idiopathic Pulmonary Fibrosis), etc.
Browse the complete report @ https://www.orbisresearch.com/reports/index/global-autoimmune-disease-therapeutics-market-size-and-forecast-with-impact-analysis-of-covid-19-2021-2025
Some Points from Table of Content:
1. Executive Summary
2. Introduction
2.1 Autoimmune Disease: An Overview
2.1.1 Most Common Autoimmune Diseases
2.1.2 Areas Affected by Autoimmune Diseases
2.1.3 Common Autoimmune Disease Symptoms
2.2 Autoimmune Disease Therapeutics: An Overview
2.2.1 Evolution of Autoimmune Disease Treatment Depending on the Severity of the Disease
2.3 Autoimmune Disease Therapeutics Segmentation: An Overview
2.3.1 Autoimmune Disease Therapeutics Segmentation by Drug Class
2.3.2 Autoimmune Disease Therapeutics Segmentation by Indication
2.3.3 Autoimmune Disease Therapeutics Segmentation by Distribution Channel
3. Global Market Analysis
3.1 Global Autoimmune Disease Therapeutics Market: An Analysis
3.1.1 Global Autoimmune Disease Therapeutics Market by Value
3.1.2 Global Autoimmune Disease Therapeutics Market by Drug Class (Anti-inflammatory, Interferons, NSAIDs, Antihyperglycemics and Others)
3.1.3 Global Autoimmune Disease Therapeutics Market by Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes and Other Indications)
3.1.4 Global Autoimmune Disease Therapeutics Market by Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America)
3.2 Global Autoimmune Disease Therapeutics Market: Drug Class Analysis
3.2.1 Global Anti-Inflammatory Autoimmune Disease Therapeutics Market by Value
3.2.2 Global Interferons Autoimmune Disease Therapeutics Market by Value
3.2.3 Global NSAIDs Autoimmune Diseases Therapeutics Market by Value
3.2.4 Global Antihyperglycemics Autoimmune Disease Therapeutics Market by Value
3.2.5 Global Others Autoimmune Disease Therapeutics Market by Value
3.3 Global Autoimmune Disease Therapeutics Market: Indication Analysis
3.3.1 Global Rheumatoid Arthritis Therapeutics Market by Value
3.3.2 Global Type 1 Diabetes Therapeutics Market by Value
3.3.3 Global Multiple Sclerosis Therapeutics Market by Value
3.3.4 Global Inflammatory Bowel Disease Therapeutics Market by Value
3.3.5 Global Other Indications Therapeutics Market by Value
...........Continued
ABOUT US:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600
Phone: +1 (972)-362-8199
Website: https://www.orbisresearch.com
Source: MarketersMedia
Release ID: 89005535
Pfizer will no longer sell its hormone replacement therapy Premarin in Canada following an internal review. The product has been available as a vaginal cream and three strengths of oral tablets.
“Washington has the Smithsonian, London has the British Museum, but Parramatta has the Powerhouse.” So declared New South Wales Premier Chris Minns at the museum’s opening on November 7, in a comment crafted more for applause than proportion. Parramatta is the heart of Sydney’s fast-growing west, about 25km (15.5 miles) from the city centre, and until now has had no major state cultural institution. The A$915 million (US$626 million) Powerhouse Parramatta is the Australian state’s biggest...
Dominic Fike confirmed he is a father in an interview with music discovery platform and blog Pigeons & Planes in April. The musician, who first hinted that he had welcomed a child when he referred to himself as a “baby father” in a lyric from his feature on Jennie’s 2025 track “Love Hangover”, spoke at length about how fatherhood had changed him. “I just don’t party like that right now. I got a son, Rocket, he’s almost two,” Fike said during the interview. “He motivates me to be stable and...
Discussing the issue of contact sports and the threat to sports men and women of all ages, particularly in the light of the recent death, just last month, of a 17-year-old French woman after a head collision on the rugby field, FRANCE 24's Mark Owen speaks with Dr Daniel H Daneshvar, Associate Professor at Harvard Medical School. He says that "there's not such thing as safe" in contact sports, explaining that "if you get a lot of repeated hits to the head, then you're at risk for problems later in life, both in the near term and the long term".
Israeli fire killed 11 people in Gaza on Thursday, six of them in the bombing of Nasser hospital in south Gaza early in the day, health officials said, the deadliest single strike since Israel's elections last month. FRANCE 24's Mark Owen speaks with Dr Goher Rahbour, a surgeon working at the Nasser Hospital.
Airbus hat den seit 21 Jahren bestehenden Entfernungsrekord von Boeing für Verkehrsflugzeuge gebrochen. Ein 24-stündiger Flug mit einem A350-1000ULR bestätigte die Technologie, die den für 2027 geplanten Nonstop-Verbindungen von Qantas zwischen Sydney und London sowie New York zugrunde liegt. The post Airbus bricht Boeings 21 Jahre alten Distanzrekord mit 24-stündigem A350-Flug appeared first on Business Traveller.
Nicht nur in Schwellenländern herrscht dicke Luft. Auch europäische Metropolen erreichen erhöhte Werte. Wichtig: Wer dorthin muss, sollte auf ein paar Dinge achten. The post Feinstaub: Die Städte mit den größten Smogproblemen appeared first on Business Traveller.
Developed in collaboration with tennis star Novak Djokovic, the performance-led wellness brand will debut in Miami's Brickell district. The post Aman Enlists Djokovic for New Ultra-Luxury Wellness and Sports Retreat appeared first on Business Traveller.
Middle-aged men should undergo regular screening for prostate cancer, the American Cancer Society said Thursday in a major change to U.S. guidelines. It comes a month after the Canadian Cancer Society urged a new national advisory body to update its prostate cancer guidelines.
Emily Marsden reports from Geneva on Vacheron Constantin’s first vintage-watch concours, where collectors unveiled their rarest pieces and judges chose the finest. The post The World’s Most Beautiful Vintage Watches? Vacheron Constantin’s Inaugural Award Winners appeared first on Business Traveller.
"It’s like going back into the olden days." View Entire Post ›
Turkish Airlines tried to wiggle out of paying for a passenger’s $512 overnight stay after a stomach-churning malfunction forced it to cancel a flight in Denver.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.